{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-049561","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.875719+00:00","generated_at":"2026-05-29T04:42:45.366349+00:00","sec_items":["1.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hepion terminates merger with Pharma Two B; special meeting cancelled","bullets":["Merger Agreement with Pharma Two B Ltd. terminated mutually on Dec 10, 2024.","No termination fee payable by either party.","Special stockholders meeting scheduled for Dec 12, 2024 cancelled; proposals withdrawn.","Nasdaq would not exclude historical losses from burn-rate calculation, leading to termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-049561","json":"https://secwatch.observer/filing/0001493152-24-049561.json","markdown":"https://secwatch.observer/filing/0001493152-24-049561.md","text":"https://secwatch.observer/filing/0001493152-24-049561.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/0001493152-24-049561-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:42:45.366349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}